{"transactions":[{"id":1775639,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-09-21T13:15:29.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":258750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award covering shares of Company Common Stock that is subject to vesting conditions based solely on continued employment or service granted under an Issuer equity plan (each, a \"Company RSU\") and each performance stock unit award covering shares of Company Common Stock that are subject to performance-based vesting conditions granted under an Issuer equity plan (each, a \"Company PSU\") (the Company RSUs and the Company PSUs, collectively \"Company Equity Awards\") that was then outstanding was cancelled, and the holder of such cancelled Company Equity Award is entitled, in exchange therefor, to receive (without interest and less applicable tax withholdings) (i) an amount in cash equal to the product of (A) the total number of shares of Company Common Stock subject to (or deliverable under) such Company Equity Award immediately prior to the Effective Time multiplied by (B) the Cash Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) and (ii) a CVR Payment for each share of Company Common Stock subject thereto (the \"Equity Award Consideration\"), provided, that any payment of the Equity Award Consideration in respect of an unvested Company Equity Award will remain subject to the same vesting conditions as were applicable to such Company Equity Award immediately prior to the Effective Time and shall only become payable to the holder of such cancelled Company Equity Award to the extent such vesting conditions are satisfied following the closing of the Merger. If provided for pursuant to a subscription agreement entered into among the Reporting Person, the Issuer and Resistance TopCo L.P., a Delaware limited partnership (\"Topco LP\"), the settlement of such Equity Award Consideration may also be made inequity interests of Topco LP."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019351/doc4.xml","form_type":"4"}},{"id":1775638,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-09-21T13:15:29.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1069231,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 6, 2023, by and among the Issuer, Resistance Acquisition, Inc. (\"Parent\"), and Resistance Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Issuer with the Issuer being the surviving corporation (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock of the Issuer (\"Company Common Stock\") was cancelled and retired and automatically converted into the right to receive (x) $2.15, payable to the holder thereof in cash, without interest (the \"Cash Consideration\") but subject to reduction for any applicable withholding taxes payable in respect thereof and (y) one (1) contractual contingent value right  (a \"CVR Payment\") that represents the right to receive $0.85 upon satisfaction of certain conditions set forth in a Contingent Value Rights Agreement, dated September 21, 2023, by and between Parent and Equiniti Trust Company, LLC."}],"balance_after":258750,"source":{"system":"sec-edgar","filing":"0000899243-23-019351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019351/doc4.xml","form_type":"4"}},{"id":1811053,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-08-10T20:26:53.000Z","date":"2023-08-09","kind":"sale","planned":false,"acquired":false,"shares":48967,"price":2.2,"value":107727.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.19 to $2.21. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":1327981,"source":{"system":"sec-edgar","filing":"0000904454-23-000472","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445423000472/edgar.xml","form_type":"4"}},{"id":1811052,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-08-10T20:26:53.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on March 30, 2021 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2023."}],"balance_after":1376948,"source":{"system":"sec-edgar","filing":"0000904454-23-000472","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445423000472/edgar.xml","form_type":"4"}},{"id":1972644,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T20:50:26.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date."}],"balance_after":28000,"derivative":{"exercise_price":1.705,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001140361-23-010163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036123010163/form4.xml","form_type":"4"}},{"id":2077904,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-12-22T16:44:51.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":23489,"price":1.99,"value":46743.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.94 to $2.01. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":1208198,"source":{"system":"sec-edgar","filing":"0000904454-22-000653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000653/edgar.xml","form_type":"4"}},{"id":2077903,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-12-22T16:44:51.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on March 15, 2022 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on December 20, 2022."}],"balance_after":1231687,"source":{"system":"sec-edgar","filing":"0000904454-22-000653","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000653/edgar.xml","form_type":"4"}},{"id":2086755,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-12-14T20:08:28.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":61919,"price":1.96,"value":121361.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit awards, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.93 to $2.01. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":1179187,"source":{"system":"sec-edgar","filing":"0000904454-22-000627","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000627/edgar.xml","form_type":"4"}},{"id":2086754,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-12-14T20:08:28.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":37831,"price":1.98,"value":74905.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit awards, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.96 to $2.00. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":1241106,"source":{"system":"sec-edgar","filing":"0000904454-22-000627","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000627/edgar.xml","form_type":"4"}},{"id":2128688,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-11-01T19:58:26.000Z","date":"2022-10-28","kind":"sale","acquired":false,"shares":8805,"price":3.47,"value":30553.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, as previously reported in a Form 4 filed with the Securities and Exchange Commission (the \"SEC\") on October 27, 2022, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.43 to $3.55. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":1278937,"source":{"system":"sec-edgar","filing":"0000904454-22-000532","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000532/edgar.xml","form_type":"4"}},{"id":2131160,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-10-27T19:06:47.000Z","date":"2022-10-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 25, 2022."}],"balance_after":1287742,"source":{"system":"sec-edgar","filing":"0000904454-22-000510","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000510/edgar.xml","form_type":"4"}},{"id":2189813,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-10T21:06:11.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":44519,"price":2.66,"value":118420.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.58 to $2.78. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":1257742,"source":{"system":"sec-edgar","filing":"0000904454-22-000429","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000429/edgar.xml","form_type":"4"}},{"id":2189812,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-10T21:06:11.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":152727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 19, 2020 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2022."}],"balance_after":1302261,"source":{"system":"sec-edgar","filing":"0000904454-22-000429","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000429/edgar.xml","form_type":"4"}},{"id":2320256,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T20:41:34.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":236250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 15/45 of the shares subject to the restricted stock units on December 10, 2022, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":1149534,"source":{"system":"sec-edgar","filing":"0000904454-22-000268","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000268/edgar.xml","form_type":"4"}},{"id":2337394,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:06:36.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":12000,"derivative":{"exercise_price":5.1,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-22-009258","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009258/form4.xml","form_type":"4"}},{"id":2337393,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-11T21:06:36.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001140361-22-009258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009258/form4.xml","form_type":"4"}},{"id":2471977,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-12-15T20:45:19.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":49259,"price":4.27,"value":210335.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.11 to $4.34. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4 to this Form 4."}],"balance_after":913284,"source":{"system":"sec-edgar","filing":"0000904454-21-000840","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000840/edgar.xml","form_type":"4"}},{"id":2471976,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-12-15T20:45:19.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":23834,"price":4.37,"value":104154.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.20 to $4.48. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":962543,"source":{"system":"sec-edgar","filing":"0000904454-21-000840","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000840/edgar.xml","form_type":"4"}},{"id":2471975,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-12-15T20:45:19.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":13983,"price":4.42,"value":61804.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.31 to $4.52. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":986377,"source":{"system":"sec-edgar","filing":"0000904454-21-000840","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000840/edgar.xml","form_type":"4"}},{"id":2598293,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-08-18T19:29:42.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":33931,"price":5.12,"value":173726.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $5.02 to $5.22. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":1000360,"source":{"system":"sec-edgar","filing":"0000904454-21-000630","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000630/edgar.xml","form_type":"4"}},{"id":2598292,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-08-18T19:29:42.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 16, 2021."}],"balance_after":1034291,"source":{"system":"sec-edgar","filing":"0000904454-21-000630","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000630/edgar.xml","form_type":"4"}},{"id":2677939,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-06-08T19:25:49.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":36654,"price":9.7,"value":355543.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.58 to $9.97. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":959291,"source":{"system":"sec-edgar","filing":"0000904454-21-000512","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000512/edgar.xml","form_type":"4"}},{"id":2677938,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-06-08T19:25:49.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":91636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 19, 2020 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on May 27, 2021."}],"balance_after":995945,"source":{"system":"sec-edgar","filing":"0000904454-21-000512","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000512/edgar.xml","form_type":"4"}},{"id":2764698,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-01T18:43:52.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":303750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 15/45 of the shares subject to the restricted stock units on December 10, 2021, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":904309,"source":{"system":"sec-edgar","filing":"0000904454-21-000395","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000395/edgar.xml","form_type":"4"}},{"id":2789031,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T19:30:02.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in equal monthly installments over 12 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":9.99,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-020585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020585/doc4.xml","form_type":"4"}},{"id":2789030,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T19:30:02.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":2000,"price":10.14,"value":20280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $10.14 to $10.18, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-21-020585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020585/doc4.xml","form_type":"4"}},{"id":2789029,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T19:30:02.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2021."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-020585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020585/doc4.xml","form_type":"4"}},{"id":2877799,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T02:01:23.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":5.5,"exercise_date":"2022-02-03","expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-21-002140","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921002140/rdgdoc.xml","form_type":"4"}},{"id":2944890,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-15T19:56:40.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":26415,"price":6.71,"value":177244.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $6.58 to $6.91. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":600559,"source":{"system":"sec-edgar","filing":"0000904454-20-000822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000822/edgar.xml","form_type":"4"}},{"id":2944889,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-15T19:56:40.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":18585,"price":6.95,"value":129165.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $6.82 to $7.14. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":626974,"source":{"system":"sec-edgar","filing":"0000904454-20-000822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000822/edgar.xml","form_type":"4"}},{"id":2979920,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-16T18:36:14.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":20928,"price":5.93,"value":124103.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $5.84 to $6.18. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":645559,"source":{"system":"sec-edgar","filing":"0000904454-20-000761","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000761/edgar.xml","form_type":"4"}},{"id":2979919,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-16T18:36:14.000Z","date":"2020-11-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on November 12, 2020."}],"balance_after":666487,"source":{"system":"sec-edgar","filing":"0000904454-20-000761","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000761/edgar.xml","form_type":"4"}},{"id":2996651,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-02T16:50:05.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":39479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The Issuer entered into an Agreement and Plan of Merger and Reorganization, dated as of June 30, 2014 (the \"Merger Agreement\"), by and among the Issuer, Tigris Merger Sub, Inc., Tigris Acquisition Sub, LLC and a Delaware corporation then known as Paratek Pharmaceuticals, Inc. (\"Old Paratek\"). On June 29, 2014, the Reporting Person was granted an option to purchase 1,169,742 shares of the common stock of Old Paratek under Old Paratek's 2014 Equity Incentive Plan at a per share exercise of price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 78,957 shares of the Issuer's common stock at a per share exercise price of $4.30."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vested and became exercisable in a series of 48 successive equal monthly installments commencing on January 1, 2015, subject generally to the Reporting Person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":4.3,"expiration_date":"2024-06-28","underlying":"Common Stock","underlying_shares":39479},"source":{"system":"sec-edgar","filing":"0000904454-20-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000693/edgar.xml","form_type":"4"}},{"id":2996650,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-02T16:50:05.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":39479,"price":4.3,"value":169759.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock acquired from the exercise of a stock option."}],"balance_after":591487,"source":{"system":"sec-edgar","filing":"0000904454-20-000693","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000693/edgar.xml","form_type":"4"}},{"id":3149152,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-14T18:27:25.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":9595,"price":4.75,"value":45576.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon settlement of performance-based restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.59 to $4.85. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":552008,"source":{"system":"sec-edgar","filing":"0000904454-20-000359","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000359/edgar.xml","form_type":"4"}},{"id":3210791,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T17:27:36.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":5.6,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-018988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120018988/doc4.xml","form_type":"4"}},{"id":3210790,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T17:27:36.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-018988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120018988/doc4.xml","form_type":"4"}},{"id":3256778,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-21T21:11:49.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on December 10, 2020, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":561603,"source":{"system":"sec-edgar","filing":"0000904454-20-000226","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000226/edgar.xml","form_type":"4"}},{"id":3341132,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-12-16T18:06:04.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":14514,"price":3.1,"value":44993.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.04 to $3.13. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":417603,"source":{"system":"sec-edgar","filing":"0000904454-19-000741","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000741/edgar.xml","form_type":"4"}},{"id":3396086,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-10-08T20:55:41.000Z","date":"2019-10-08","kind":"sale","acquired":false,"shares":7818,"price":3.82,"value":29864.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.76 to $3.88. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":432117,"source":{"system":"sec-edgar","filing":"0000904454-19-000678","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000678/edgar.xml","form_type":"4"}},{"id":3396085,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-10-08T20:55:41.000Z","date":"2019-10-04","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 4, 2019."}],"balance_after":439935,"source":{"system":"sec-edgar","filing":"0000904454-19-000678","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000678/edgar.xml","form_type":"4"}},{"id":3396711,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-10-07T17:13:34.000Z","date":"2019-10-03","kind":"sale","acquired":false,"shares":16265,"price":3.98,"value":64734.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.81 to $4.21. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":413935,"source":{"system":"sec-edgar","filing":"0000904454-19-000669","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000669/edgar.xml","form_type":"4"}},{"id":3579608,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-03-25T21:50:11.000Z","date":"2019-03-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":14.31,"expiration_date":"2029-03-20","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-021279","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119021279/doc4.xml","form_type":"4"}},{"id":3626573,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2019-02-28T18:55:35.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on December 10, 2019, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":430200,"source":{"system":"sec-edgar","filing":"0000904454-19-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000282/edgar.xml","form_type":"4"}},{"id":3677742,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2019-02-04T16:37:03.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs will settle in shares of Common Stock on May 8, 2020, provided that the Reporting Person remains in continuous service with Paratek Pharmaceuticals, Inc. through the settlement date."}],"balance_after":310200,"source":{"system":"sec-edgar","filing":"0000904454-19-000149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000149/edgar.xml","form_type":"4"}},{"id":3730867,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-12-14T17:35:40.000Z","date":"2018-12-13","kind":"sale","acquired":false,"shares":6000,"price":6.27,"value":37620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $6.25 to $6.28. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":277700,"source":{"system":"sec-edgar","filing":"0000904454-18-000783","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000783/edgar.xml","form_type":"4"}},{"id":3730866,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-12-14T17:35:40.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":5525,"price":6.76,"value":37349.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $6.55 to $7.15. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":283700,"source":{"system":"sec-edgar","filing":"0000904454-18-000783","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000783/edgar.xml","form_type":"4"}},{"id":3789955,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-10-16T19:51:20.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":5200,"price":8.96,"value":46592.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.93 to $9.02. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":289225,"source":{"system":"sec-edgar","filing":"0000904454-18-000663","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000663/edgar.xml","form_type":"4"}},{"id":3789954,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-10-16T19:51:20.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 12, 2018."}],"balance_after":294425,"source":{"system":"sec-edgar","filing":"0000904454-18-000663","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000663/edgar.xml","form_type":"4"}},{"id":3796832,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-10-04T20:41:45.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":8861,"price":9.82,"value":87015.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover personal income tax obligations upon vesting of PRSUs, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.75 to $9.95. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4 to this Form 4."}],"balance_after":281425,"source":{"system":"sec-edgar","filing":"0000904454-18-000642","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/edgar.xml","form_type":"4"}},{"id":3796831,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-10-04T20:41:45.000Z","date":"2018-10-02","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents PRSUs granted on August 3, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 2, 2018. These PRSUs will settle in shares of common stock on October 2, 2019, provided that the Reporting Person remains in continuous service with Paratek Pharmaceuticals, Inc. through the settlement date."}],"balance_after":290286,"source":{"system":"sec-edgar","filing":"0000904454-18-000642","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/edgar.xml","form_type":"4"}},{"id":3796830,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-10-04T20:41:45.000Z","date":"2018-10-02","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units (\"PRSUs\") granted on February 2, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 2, 2018."}],"balance_after":235286,"source":{"system":"sec-edgar","filing":"0000904454-18-000642","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/edgar.xml","form_type":"4"}},{"id":3872839,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-07-05T18:46:24.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":12000,"price":9.97,"value":119640.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.93 to $10.03. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":202786,"source":{"system":"sec-edgar","filing":"0000904454-18-000462","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000462/edgar.xml","form_type":"4"}},{"id":3966234,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-04-10T19:40:46.000Z","date":"2018-04-09","kind":"sale","acquired":false,"shares":8084,"price":12.7,"value":102666.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $12.60 to $12.85. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":214786,"source":{"system":"sec-edgar","filing":"0000904454-18-000285","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000285/edgar.xml","form_type":"4"}},{"id":3968539,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-04-05T18:42:14.000Z","date":"2018-04-03","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units granted on February 2, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on April 3, 2018."}],"balance_after":222870,"source":{"system":"sec-edgar","filing":"0000904454-18-000277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000277/edgar.xml","form_type":"4"}},{"id":3992185,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T20:25:43.000Z","date":"2018-03-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 14, 2018 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":9.5,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-020457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919118020457/doc4.xml","form_type":"4"}},{"id":4052251,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-02-16T16:52:08.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":58500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan.  Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.  The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on December 10, 2018, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":203370,"source":{"system":"sec-edgar","filing":"0000904454-18-000185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000185/edgar.xml","form_type":"4"}},{"id":4072275,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2018-02-07T18:23:07.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":3040,"price":14.22,"value":43228.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.43, inclusive. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":144870,"source":{"system":"sec-edgar","filing":"0000904454-18-000138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000138/edgar.xml","form_type":"4"}},{"id":4207058,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-18T17:33:47.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 36 months measured from September 15, 2017 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":25000,"derivative":{"exercise_price":11.15,"expiration_date":"2027-09-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-053205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919117053205/doc4.xml","form_type":"4"}},{"id":4253329,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-21T16:38:50.000Z","date":"2017-07-19","kind":"exercise","acquired":false,"shares":39478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The Issuer entered into an Agreement and Plan of Merger and Reorganization, dated as of June 30, 2014 (the \"Merger Agreement\"), by and among the Issuer, Tigris Merger Sub, Inc., Tigris Acquisition Sub, LLC and a Delaware corporation then known as Paratek Pharmaceuticals, Inc. (\"Old Paratek\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 29, 2014, the Reporting Person was granted an option to purchase 1,169,742 shares of the common stock of Old Paratek under Old Paratek's 2014 Equity Incentive Plan at a per share exercise of price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 78,957 shares of the Issuer's common stock at a per share exercise price of $4.30 upon closing of the merger. The option was previously reported on Form 4 filed on November 3, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for this stock option is as follows: 1/48th (2.1%) of the option, or approximately 1,645 shares, vests and becomes exercisable on each of the 48 months commencing on January 1, 2015, subject generally to the Reporting Person's continued employment with the Issuer"}],"balance_after":39479,"derivative":{"exercise_price":4.3,"expiration_date":"2024-06-28","underlying":"Common Stock","underlying_shares":39478},"source":{"system":"sec-edgar","filing":"0000904454-17-000529","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000529/edgar.xml","form_type":"4"}},{"id":4253328,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-07-21T16:38:50.000Z","date":"2017-07-19","kind":"exercise","acquired":true,"shares":39478,"price":4.3,"value":169755.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock acquired from the exercise of a stock option."}],"balance_after":147910,"source":{"system":"sec-edgar","filing":"0000904454-17-000529","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000529/edgar.xml","form_type":"4"}},{"id":4262073,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-07-06T17:00:21.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":4351,"price":23.5788,"value":102591.3588,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.45 to $23.90, inclusive. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":108432,"source":{"system":"sec-edgar","filing":"0000904454-17-000503","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000503/edgar.xml","form_type":"4"}},{"id":4262072,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-07-06T17:00:21.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted stock units granted on February 2, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on July 3, 2017."}],"balance_after":112783,"source":{"system":"sec-edgar","filing":"0000904454-17-000503","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000503/edgar.xml","form_type":"4"}},{"id":4461684,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":22,"price":15.09,"value":331.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":99783,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4461683,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":1082,"price":15.05,"value":16284.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":99805,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4461682,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":16,"price":15.075,"value":241.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":100887,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4461681,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":1302,"price":15.1,"value":19660.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":100903,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4461680,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":668,"price":15.15,"value":10120.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":102205,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4461679,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Common Stock","published_at":"2017-02-08T18:35:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":16,"price":15.2,"value":243.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."}],"balance_after":102873,"source":{"system":"sec-edgar","filing":"0000904454-17-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000135/edgar.xml","form_type":"4"}},{"id":4466512,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO and CMO"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-06T19:13:18.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares shall vest as to 1/36 of the shares on the one-month anniversary following February 2, 2017 and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service to the Company at each vesting date."}],"balance_after":65000,"derivative":{"exercise_price":15.1,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000904454-17-000099","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000099/edgar.xml","form_type":"4"}},{"id":4603073,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":109530,"kind":"person","name":"Loh Evan","position":1,"cik":"0001622680","reported_name":"Loh Evan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-14T16:16:04.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares shall vest in 12 equal monthly installments commencing on October 12, 2016."}],"balance_after":12300,"derivative":{"exercise_price":7.77,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001104659-16-144633","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622680/000110465916144633/a4.xml","form_type":"4"}}]}